20
Influenza A – What’s Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab [email protected]

Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab [email protected]

Embed Size (px)

Citation preview

Page 1: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca

Influenza A – What’s Hot

TARRANT Symposium 2012

Kevin Fonseca

Clinical Virologist

ProvLab

[email protected]

Page 2: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca

Theme

Recent Controversies in Influenza Research

Animal Models Lively Discussion

Page 3: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca

Holy Grail of “Influenzaologists”

The Perfect Vaccine Able to predict Pandemics to the day/hour Able to clinically diagnose with 100%

certainty The Perfect Influenza test in 10 secs The Perfect Model

Page 4: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 5: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca

Controversy Balance the right to research with perceived

ethical obligations Create a potential bio-weapon Provide data to “terrorist organisations” Risks of pathogen escape (small-pox, anthrax,

influenza) Safety of the public What about “military research” When is research just to dangerous to conduct Does understanding the biology of infection in

animal models really help ?

Page 6: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca

Mortality = 58%

Page 7: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 8: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 9: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 10: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca

Belser et al Disease Models & Mechanisms 2011

Page 11: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 12: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 13: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca

Pandemic vs Seasonal H1N1 (Pre-pandemic)

Virus Ferrets Humans

Pandemic

Mild

Severe

Fatal

30% sneezed

No deaths

Found in GI (70%)

Generally mild

Not associated with GI symptoms

Lots of person-to-person transmission

Spectrum of illness with some fatalities

Some countries reported higher incidences or morbidity & mortality

50% sneezed

50% died

Found in GI (20%) [& contacts]

10% sneezed

No deaths

Found in GI (10%)

Seasonal 100% sneezed

No deaths

No GI infection

Generally mild

No GI symptoms

Fatalities occurred

Q – How accurate was the ferret model in predicting human disease ?

Page 14: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 15: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 16: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 17: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 18: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca
Page 19: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca

Reality ?

Ferret Model A(H3N2)v is easily

transmissible Causes mild illness

Human Cell Model A(H3N2)v > H3N2 Reaches a higher

titre

Observed Handful of cases (12) Mainly in young

children Mild illness Few hospitalizations Low level of

transmission thus far ? Pandemic

potential? Not covered by the

vaccine

Page 20: Influenza A – Whats Hot TARRANT Symposium 2012 Kevin Fonseca Clinical Virologist ProvLab Kevin.fonseca@albertahealthservices.ca